DOT for TB, ARV, needle and syringe exchange, MST, psychological counselling and support, social and juridical support provided in the same place

Size: px
Start display at page:

Download "DOT for TB, ARV, needle and syringe exchange, MST, psychological counselling and support, social and juridical support provided in the same place"

Transcription

1 DOT for TB, ARV, needle and syringe exchange, MST, psychological counselling and support, social and juridical support provided in the same place Veronika Iljina, MD East-Viru Central Hospital, National TB Programm

2 New HIV+ cases and total number of notified HIV+ cases (cumulatively) New HIV+ cases Total No of HIV+ cases

3 TB notification rate and incidence by year and TB/HIV+ co-infected cases TB register 2013

4 Hospital Care All TB patients are recommended to be tested for HIV Currently testing is performed for 90% of TB patients (in some cases TB is diagnosed after the patient death) Monitoring the health and treatment of co-infected people is done by TB specialists in collaboration with Infection Disease Doctors

5 Hospital Care TB treatment for all TB patients is free of charge and according to DOTS/DOTS plus recommendations including prison ART in is currently provided by 4 Hospitals, are obtained mainly by public procurement and free to all persons During TB treatment in EVC Hospital ARV treatment is related with DOTS

6 Ambulatory Care According to DOTS/DOTS plus recommendation Since 2011 TB/ARV/OST providing under DOT Food package and transportation costs are provided which supports patients to take their medication Social worker support Contracts with GP nurses for providing TB DOT Contracts with Corrigo Center for TB/ARV/OST providing under DOT

7 ARVT Initiation of ART is based on clinical and immunological assessment CD4 count is still the most important indicator for initiation of therapy Monitoring of treatment effects with plasma viral load

8 HIV-TB programmes collaborations TB and Infection Disease doctors held United Consilium for TB/HIV+ patients on regular basis (two times a year) since 2008 For each consilium TB Doctors will prepare analyzes and TB treatment scheme for a patient Infection Disease Doctors will evaluate the immune status of a patient and issue of give recommendations for ART and render assistance in evaluating the results of ART

9 Co-infected TB/HIV+ (new+relapses) TB/HIV+ co-infected patients in 18 (37,2%) in Ida-Virumaa - 10 (27,7%) in EVC Hospital (42%) in 2011

10 TB treatment North Medical Centre, Kose Department -100 beds (70) Tartu University Clinic, TB Department -24 beds East-Viru Central Hospital, TB Department-16 beds (24) Narva Hospital, Infection Disease Department- 12 beds Viljandi Hospital, TB Department 24 beds (incl. beds for involuntary treatment)

11 East-Viru Central Hospital (EVC Hospital) TB Department In- patient department for 18 beds (28) Out- patient department (4 doctors ) DOT office

12 Registered TB cases , 2012* by county (new and relapses) Maakond/ aasta Harjumaa Hiiumaa Ida-Virumaa Jõgevamaa Järvamaa Lääne-Virumaa Läänemaa Põlvamaa Pärnumaa Raplamaa Saaremaa Tartumaa Valgamaa Viljandimaa Võrumaa Vanglad Kokku TB Register 2013, 2012 andmed on esialgsed

13 East-Viru Central Hospital TB Department The first co-infected patient was registered in 2001 In 2009 there was 42% HIV positive among TB patients in East-Viru Central Hospital (10% average in ) In 2012 there was 32% HIV positive among TB patients (15% average in ) MST since During OST have got 40 patients, 15 of them got triple treatment (TB, ARV, OST) *MST-methadon substitution treatment *OST-opioid substitution therapy

14 MST Average daily dose varies from 30 to 280ml Prescription and dosage correction by psychiatrist before and during TB Treatment OST was given for patients at the definite time in the morning Methadone was ordered from Central pharmacy of the Hospital

15 Results Improved quality of TB+ARV treatment Better results in treatment among TB/HIV patients Decrease of default rate among TB/HIV patients

16 Thank you!

Detection of HEV in Estonia. Anna Ivanova, Irina Golovljova, Valentina Tefanova

Detection of HEV in Estonia. Anna Ivanova, Irina Golovljova, Valentina Tefanova Detection of HEV in Estonia Anna Ivanova, Irina Golovljova, Valentina Tefanova National Institute for Health Development Department of Virology Zoonotic pathogens Tick-borne pathogens: TBEV, Borrelia sp.,

More information

Implementing TB/HIV collaborative activities in prison settings: where are we?

Implementing TB/HIV collaborative activities in prison settings: where are we? Implementing TB/HIV collaborative activities in prison settings: where are we? Severin Lilian (1), Morosan Vitali (1), Doltu Svetlana (2), Ilona Burduja (2), Viorel Soltan (3), Sain Dmitri (4) (1)Carlux

More information

Prevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs

Prevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs Prevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs Aljona Kurbatova National Institute for Health Development Estonia Estimated number of people who inject

More information

NSPs in Estonia: current situation and future challenges

NSPs in Estonia: current situation and future challenges NSPs in Estonia: current situation and future challenges Aljona Kurbatova National Institute for Health Development Riga, 25.10.2010 1 Background First NSP project was launched in May 1997 needle and syringe

More information

The Comprehensive Package: The simple truth about our response to drug related HIV. Dr. Monica Beg, Signe Rotberga UNODC

The Comprehensive Package: The simple truth about our response to drug related HIV. Dr. Monica Beg, Signe Rotberga UNODC The Comprehensive Package: The simple truth about our response to drug related HIV Dr. Monica Beg, Signe Rotberga UNODC HIV among injecting drug users Why is it so important? 30% global HIV infections

More information

FIGHTING HIV IN ESTONIA IN 2006 AND Aire Trummal, Liilia Lõhmus, Kristi Rüütel

FIGHTING HIV IN ESTONIA IN 2006 AND Aire Trummal, Liilia Lõhmus, Kristi Rüütel FIGHTING HIV IN ESTONIA IN 2006 AND 2007 Aire Trummal, Liilia Lõhmus, Kristi Rüütel Tallinn 2008 TABLE OF CONTENTS INTRODUCTION... 3 1. TRENDS OF HIV TRANSMISSION IN ESTONIA... 4 2. STRUCTURES FOR IMPLEMENTING

More information

Minutes of the 18 th HIV/AIDS Think Tank Meeting 5 and 6 June 2012, Luxembourg

Minutes of the 18 th HIV/AIDS Think Tank Meeting 5 and 6 June 2012, Luxembourg EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL Directorate C - Public Health and Risk Assessment C4 - Health determinants Minutes of the 18 th HIV/AIDS Think Tank Meeting 5 and 6 June 2012,

More information

ANNUAL PROJECT PROGRESS REPORT FOR 2008 (draft)

ANNUAL PROJECT PROGRESS REPORT FOR 2008 (draft) ANNUAL PROJECT PROGRESS REPORT FOR 2008 (draft) Project Title: HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Project Number: XEEJ20 Total

More information

Drug treatment and prevention in Tartu prison. Maret Miljan Department of Prisons Ministry of Justice Estonia

Drug treatment and prevention in Tartu prison. Maret Miljan Department of Prisons Ministry of Justice Estonia Drug treatment and prevention in Tartu prison Maret Miljan Department of Prisons Ministry of Justice Estonia Prisons in Estonia 3470 prisoners (25.05.2010): 2768 convicted 702 held under custody 5 prisons:

More information

Tajikistan National Report. Summary HARM REDUCTION WORKS FUND IT! Arguments for strategic investment. Summary of National Report: Tajikistan

Tajikistan National Report. Summary HARM REDUCTION WORKS FUND IT! Arguments for strategic investment. Summary of National Report: Tajikistan HARM REDUCTION WORKS FUND IT! National Report Summary Arguments for strategic investment With the support of The present document contains a summary of the key conclusions and recommendations provided

More information

Overview of the Activities of Estonian Pharmacies

Overview of the Activities of Estonian Pharmacies No of inhabitants Overview of the Activities of Estonian Pharmacies Number of Pharmacies There are three types of pharmacies in Estonia: general pharmacies, veterinary pharmacies and hospital pharmacies.

More information

Prevalence of HIV and risk behaviors among injecting drug users in Tallinn, Estonia in a series of cross-sectional studies

Prevalence of HIV and risk behaviors among injecting drug users in Tallinn, Estonia in a series of cross-sectional studies Prevalence of HIV and risk behaviors among injecting drug users in Tallinn, Estonia in a series of cross-sectional studies Sigrid Vorobjov 1, Maris Salekešin 1, Katri Abel-Ollo 1, Anneli Uusküla 2, Don

More information

ASF in 2016 Estonia. PAFF meeting

ASF in 2016 Estonia. PAFF meeting ASF in 2016 Estonia PAFF meeting 13-14.09.2016 General overwiew of the year 2016: 4 new infected areas in wild boar 6 new outbreaks in domestic pigs 4 backyards 2 large farms ASF in wild boars Infected

More information

Harm Reduction in Nigeria

Harm Reduction in Nigeria Harm Reduction in Nigeria Needs, gaps, and responses to ensure access to effective HIV prevention, treatment and care for people who inject drugs February 2018 This document is made possible by the generous

More information

KAZAKHSTAN. National Focal Point. Drug Abuse and Drug Dependence Treatment Situation. Territory : 2,717,300 km 2 Capital: Astana BASIC DATA

KAZAKHSTAN. National Focal Point. Drug Abuse and Drug Dependence Treatment Situation. Territory : 2,717,300 km 2 Capital: Astana BASIC DATA KAZAKHSTAN Territory : 2,717,300 km 2 Capital: Astana Map No. 3771 Rev. 6 UNITED NATIONS January 2004 BASIC DATA Total population (millions) 2009 15.5* Population under age15 (as % of total) 2010 23.8*

More information

Towards universal access

Towards universal access Key messages Towards universal access Scaling up priority HIV/AIDS interventions in the health sector September 2009 Progress report Towards universal access provides a comprehensive global update on progress

More information

26 28 May 2010, Almaty, Kazkhstan. Nina Kerimi UNODC Regional Project Coordinator 1

26 28 May 2010, Almaty, Kazkhstan. Nina Kerimi UNODC Regional Project Coordinator 1 The 16 th Core Group Meeting of the TB/HIV Working Group 26 28 May 2010, Almaty, Kazkhstan Nina Kerimi UNODC Regional Project Coordinator 1 UNODC Regional Office for Central Asia covers 6 countries: AZE,

More information

Figure 1: Newly diagnosed HIV-cases and total number of HIV-cases, (Data source: Estonian Health Board)

Figure 1: Newly diagnosed HIV-cases and total number of HIV-cases, (Data source: Estonian Health Board) UNGASS narrative report, Estonia INTRODUCTION Estonia is the smallest of the three Baltic countries with a population of approximately 1.37 million people and the percentage of non-ethnic Estonians of

More information

Review on HIV & Associated Infections in Latvia

Review on HIV & Associated Infections in Latvia Review on HIV & Associated Infections in Latvia Dr.Inga Upmace, Infectology Center of Latvia Second meeting on EG on HIV/AIDS and AI April 7, 2011, Riga Negative influences: Several reorganizations of

More information

Hepatitis and HIV Co-Infection: Situation in Ukraine.

Hepatitis and HIV Co-Infection: Situation in Ukraine. 2nd Central and Eastern European Meeting on Viral Hepatitis and Co-Infection with HIV Hepatitis and HIV Co-Infection: Situation in Ukraine. Pavlo Skala Associate Director: Policy & Partnership Ukraine

More information

Report on the epidemiological situation of HIV and AIDS and the fulfilment of National HIV and AIDS Strategy for years in year 2012

Report on the epidemiological situation of HIV and AIDS and the fulfilment of National HIV and AIDS Strategy for years in year 2012 Report on the epidemiological situation of HIV and AIDS and the fulfilment of National HIV and AIDS Strategy for years 2006 2015 in year 2012 Summary The purpose of the report is to provide information

More information

Report of the 16 th. Core Group meeting Almaty, Kazakhstan May 26-28, 2010

Report of the 16 th. Core Group meeting Almaty, Kazakhstan May 26-28, 2010 Report of the 16 th Core Group meeting Almaty, Kazakhstan May 26-28, 2010 The 16 th meeting of the Core Group of the TB/HIV Working Group of the Stop TB Partnership was conducted in Almaty, Kazakstan from

More information

CROATIA. Venija Cerovecki, MD, GP. University of Zagreb School of Medicine Department for Family Medicine

CROATIA. Venija Cerovecki, MD, GP. University of Zagreb School of Medicine Department for Family Medicine CROATIA Experiences and issues in the management of drug, health and social co-morbidities among clients in opioid substitution treatment (OST) with GPs Venija Cerovecki, MD, GP University of Zagreb School

More information

OST saves lives it s official! OST a key to HIV prevention Opioid Substitution Treatment in Germany A Story of Success

OST saves lives it s official! OST a key to HIV prevention Opioid Substitution Treatment in Germany A Story of Success XVIII International AIDS Conference, 2010 Vienna UNODC-GTZ Satellite Symposium: OST saves lives it s official! OST a key to HIV prevention Opioid Substitution Treatment in Germany A Story of Success Joerg

More information

Access to needle and syringe exchange services in Estonia

Access to needle and syringe exchange services in Estonia Access to needle and syringe exchange services in Estonia presented by Aljona Kurbatova prepared by Aire Trummal (initially prepared for the workshop How do we know what works? (BZgA, WHO), Berlin, 23.10.2008)

More information

About Project Sunrise

About Project Sunrise 1 2 About Project Sunrise FHI 360 has been awarded a five year project titled Sunrise by the Centers for Disease Control and Prevention (CDC). The project aims to complement the ongoing National AIDS Control

More information

China Country Advocacy Brief Injecting Drug Use and HIV

China Country Advocacy Brief Injecting Drug Use and HIV United Nations Regional Task Force on Injecting Drug Use and HIV/AIDS for Asia and the Pacific China Country Advocacy Brief Injecting Drug Use and HIV Key actions to be supported Expansion of the national

More information

HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications

HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications Don Des Jarlais, Ph.D. Professor of Psychiatry, Icahn School of Medicine at Mount Sinai UNODC 2014

More information

Annex 13. Indicators for HIV testing services reference sheet

Annex 13. Indicators for HIV testing services reference sheet Annex 13. Indicators for HIV testing services reference sheet Table 13.1A Programme indicators for HIV testing services WHO/HIV/2015.32 Indicator National indicators Numerator (N)/ denominator (D) Disaggregation

More information

ATLAS on substance use 2017:

ATLAS on substance use 2017: WHO Forum on alcohol, drugs and addictive behaviours Enhancing public health actions through partnerships and collaboration ATLAS on substance use 17: resources for the prevention and treatment of substance

More information

Methadone Treatment as a Harm Reduction Strategy, Gender Sensitive Programming and Evidence-based Strategies

Methadone Treatment as a Harm Reduction Strategy, Gender Sensitive Programming and Evidence-based Strategies Methadone Treatment as a Harm Reduction Strategy, Gender Sensitive Programming and Evidence-based Strategies Wendee Wechsberg, PhD, Senior Director Substance Abuse Treatment Evaluations and Interventions

More information

Goal of this chapter. 6.1 Introduction Good practices for linkage to care General care for people living with HIV 84

Goal of this chapter. 6.1 Introduction Good practices for linkage to care General care for people living with HIV 84 Clinical guidelines across THE CONTINuUM OF CARE: LINKING PEOPLE DIAGNOSEd WiTH hiv infection to hiv care and treatment 06 6.1 Introduction 84 6.2 Good practices for linkage to care 84 6.3 General care

More information

Felice Nava, MD, PhD Felice A. Nava, MD PhD

Felice Nava, MD, PhD Felice A. Nava, MD PhD Felice Nava, MD, PhD Felice A. Nava, MD PhD Direttore U.O. Sanità Penitenziaria Azienda ULSS 6 Euganea Padova Direttore Comitato Scientifico Nazionale FeDerSerD HCV 0? Dall Eradicazione del virus alla

More information

Infection Control in Tanzania

Infection Control in Tanzania Infection Control in Tanzania Dr. Peter C. Mgosha (MPH,) MINISTRY OF HEALTH AND SOCIAL WELFARE NATIONAL AIDS COTROL PROGRAMME P.O.BOX 11857 DAR Es SALAAM TANZANIA Out line Presentation Tanzania profile

More information

Technical Guidance Note for Global Fund HIV Proposals

Technical Guidance Note for Global Fund HIV Proposals Technical Guidance Note for Global Fund HIV Proposals UNAIDS I World Health Organization I 2011 Rationale for including this activity in the proposal The World Health Organization (WHO), the Joint United

More information

PALLIATIVE CARE PRESCRIBING FOR PATIENTS WHO ARE SUBSTANCE MISUSERS

PALLIATIVE CARE PRESCRIBING FOR PATIENTS WHO ARE SUBSTANCE MISUSERS PALLIATIVE CARE PRESCRIBING FOR PATIENTS WHO ARE SUBSTANCE MISUSERS Background information Substance misusers who develop palliative care needs are likely to have psychological, social and existential

More information

Current status of implementation and monitoring and evaluation of collaborative TB/HIV activities. Avinash Kanchar

Current status of implementation and monitoring and evaluation of collaborative TB/HIV activities. Avinash Kanchar Current status of implementation and monitoring and evaluation of collaborative TB/HIV activities Avinash Kanchar Outline WHO guide to M&E of collaborative TB/HIV activities: 2015 Reporting status on Global

More information

IPT Policy Review South Africa. WHO TB/HIV Working Group meeting

IPT Policy Review South Africa. WHO TB/HIV Working Group meeting IPT Policy Review South Africa WHO TB/HIV Working Group meeting Outline Background Policy Environment Policy and Guidelines TB/HIV Collaboration Policy development process BACKGROUND Population: 53 Million

More information

The impact of Global Fund transition strategies on national HIV programs in Central Asia.

The impact of Global Fund transition strategies on national HIV programs in Central Asia. The impact of Global Fund transition strategies on national HIV programs in Central Asia. Anna Deryabina, MD, MScIH, DrPH Director for Central Asia ICAP at Columbia University July 26, 2018 Introduction

More information

IPT IMPLEMENTATION- SWAZILAND EXPERIENCE

IPT IMPLEMENTATION- SWAZILAND EXPERIENCE IPT IMPLEMENTATION- SWAZILAND EXPERIENCE Gugu Mchunu-National TB/HIV coordinator Programmatic Management of Latent TB infection consultation meeting Seoul, Republic of Korea,27-28 APRIL,2016 TB Epidemiology

More information

The role of UNODC in working law enforcement agencies to promote harm reduction. IHRC, Bangkok, 23 April 2009

The role of UNODC in working law enforcement agencies to promote harm reduction. IHRC, Bangkok, 23 April 2009 The role of UNODC in working law enforcement agencies to promote harm reduction IHRC, Bangkok, 23 April 2009 Drug control has focused mostly on law enforcement Public health which is the first principle

More information

IPT BOTSWANA EXPERIENCE

IPT BOTSWANA EXPERIENCE IPT BOTSWANA EXPERIENCE Oaitse I Motsamai RN, MW, B Ed, MPH Ministry of Health Botswana 11 th November 2008 Addis Ababa, Ethiopia OUTLINE Botswana context Rationale for IPT in Botswana Pilot Current Programme

More information

Session-1: Template for country presentation (EXISTING Indicators)

Session-1: Template for country presentation (EXISTING Indicators) Session-1: Template for country presentation (EXISTING Indicators) Instruction This presentation is expected to provide Country perspective on use of following Existing indicators among the top 10 indicators

More information

Dispensing and administration of emergency opioid antagonist without a

Dispensing and administration of emergency opioid antagonist without a 68-7-23. Dispensing and administration of emergency opioid antagonist without a prescription. (a) A pharmacist may dispense an FDA-approved emergency opioid antagonist and the necessary medical supplies

More information

Tuberculosis and Early Case Finding

Tuberculosis and Early Case Finding TUBIDU III International Training in Bucharest, Romania 27th 28th of February2014 Tuberculosis and Early Case Finding Piloting of TUBIDU Handbook Abbrevationsand acronyms TB Tuberculosis MDR-TB Multi drug-resistant

More information

TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director.

TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director. 30 August 2007 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-seventh session Brazzaville, Republic of Congo, 27 31 August Provisional agenda item 7.8 TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE

More information

8.0 Take Home Naloxone

8.0 Take Home Naloxone 8.0 Take Home Naloxone 8.1 Population characteristics For the financial year (FY) 2016/17, 721 take home naloxone (THN) kits were issued in the City of Edinburgh. Of the 323 individuals who received naloxone

More information

Toronto Declaration 2014: Global Strategies to control and eliminate viral hepatitis globally. A call for coordinated action

Toronto Declaration 2014: Global Strategies to control and eliminate viral hepatitis globally. A call for coordinated action Toronto Declaration 2014: Global Strategies to control and eliminate viral hepatitis globally A call for coordinated action Disclaimer Toronto declaration is not aiming to reinvent the wheel or interfere

More information

TB Situation in Zambia/ TB Infection Control Program. Dr N Kapata Zambia National TB/Leprosy Control Programme Manager

TB Situation in Zambia/ TB Infection Control Program. Dr N Kapata Zambia National TB/Leprosy Control Programme Manager / TB Infection Control Program Dr N Kapata Zambia National TB/Leprosy Control Programme Manager Background Major public health problem Current (2014) notification rate is at 286/ 100,000 population. The

More information

HA Corporate Scholarship Program:

HA Corporate Scholarship Program: HA Corporate Scholarship Program: Substance Abuse Service in Psychiatry Ronnie Pao 02-10-10 The Maudsley Hospital Marina House Community Drug & Alcohol Team London Borough of Southwark Provides a Tier

More information

COLLABORATIVE RESEARCH ON HIV AMONG PERSONS WHO INJECT DRUGS IN TALLINN, ESTONIA, PRESENT

COLLABORATIVE RESEARCH ON HIV AMONG PERSONS WHO INJECT DRUGS IN TALLINN, ESTONIA, PRESENT COLLABORATIVE RESEARCH ON HIV AMONG PERSONS WHO INJECT DRUGS IN TALLINN, ESTONIA, 2005 - PRESENT DON C DES JARLAIS ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI ANNELI UUSKULA UNIVERSITY OF TARTU The number

More information

HIV/AIDS IN EASTERN EUROPE AND CENTRAL ASIA (EECA) Charles Ssonko HIV/TB/Hepatitis Adviser Medecins Sans Frontieres

HIV/AIDS IN EASTERN EUROPE AND CENTRAL ASIA (EECA) Charles Ssonko HIV/TB/Hepatitis Adviser Medecins Sans Frontieres HIV/AIDS IN EASTERN EUROPE AND CENTRAL ASIA (EECA) Charles Ssonko HIV/TB/Hepatitis Adviser Medecins Sans Frontieres Objectives The Epidemiology of HIV/AIDS in the EECA Region (Trends) o The Burden of HIV/AIDS

More information

TB/HIV in the WHO European Region Overview, Priorities & Response

TB/HIV in the WHO European Region Overview, Priorities & Response TB/HIV in the WHO European Region Overview, Priorities & Response 16 th Core Group Meeting TB/HIV Working Group Stop TB Partnership Almaty, Kazakhstan May 2010 Martin Donoghoe Andrei Dadu, Smiljka de Lussigny

More information

Template Control Page. Substance Misuse Newham Template Guide. Substance Misuse Newham. Date September 2015 DOCUMENT MANAGEMENT REVISION HISTORY

Template Control Page. Substance Misuse Newham Template Guide. Substance Misuse Newham. Date September 2015 DOCUMENT MANAGEMENT REVISION HISTORY Template Control Page Substance Misuse Newham Template Guide Title Substance Misuse Newham Author CEG Status Active Date September 2015 DOCUMENT MANAGEMENT REVISION HISTORY Version Date Summary of Changes

More information

epidemic among vulnerable groups

epidemic among vulnerable groups Project TUBIDU Empowering public health system and civil society to fight tuberculosis epidemic among vulnerable groups Prepared by: Aljona Kurbatova, NIHD Maarja Sukles, NIHD Liga Rusmane, LTBF What is

More information

Eliminating Viral Hepatitis in Australia: Where are we in 2017?

Eliminating Viral Hepatitis in Australia: Where are we in 2017? This document was prepared by Hepatitis Australia in consultation with a variety of stakeholders working in the areas of hepatitis B and hepatitis C in Australia. This included people involved in primary

More information

GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy

GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA The critical need to scale up opioid substitution therapy Craig McClure IAS Executive Director Outline of Presentation 1.

More information

Response to Treatment in Sputum Smear Positive Pulmonary Tuberculosis Patients In relation to Human Immunodeficiency Virus in Kano, Nigeria.

Response to Treatment in Sputum Smear Positive Pulmonary Tuberculosis Patients In relation to Human Immunodeficiency Virus in Kano, Nigeria. Response to Treatment in Sputum Smear Positive Pulmonary Tuberculosis Patients In relation to Human Immunodeficiency Virus in Kano, Nigeria. Yusuf Mohammed, Mukhtar Dauda, Ifeanyi Oyeyi TB/HIV Unit, International

More information

Implementation of Collaborative TB/HIV Activities by ICAP: Success and Challenges

Implementation of Collaborative TB/HIV Activities by ICAP: Success and Challenges Implementation of Collaborative TB/HIV Activities by ICAP: Success and Challenges Andrea Howard, M.D., M.S. 14 th Core Group Meeting of TB/HIV Working Group November 11-12 2008 Integration of TB-HIV Services

More information

COUNTRY TABLE. MONTENEGRO.

COUNTRY TABLE. MONTENEGRO. EPIDEMIOLOGICAL DATA Indicator Data Source of data/additional notes re data Year of estimate Population 620 029 National Census data 2011 Estimated number of people who inject drugs (PWID) 1282 (95%CI

More information

Scaling up priority HIV/AIDS interventions in the health sector

Scaling up priority HIV/AIDS interventions in the health sector TOWARDS UNIVERSAL ACCESS? Scaling up priority HIV/AIDS interventions in the health sector Yves Souteyrand, WHO October 2011 Towards universal access targets UN General Assembly High level Meeting June

More information

Methods: respondent driven sampling (RDS) was used to recruit PWID

Methods: respondent driven sampling (RDS) was used to recruit PWID RDS study among PWID in Kohtla-Järve, north-east of Estonia: prevalence of HIV and risk behaviours (an update, based on 216 study, and methodological considerations) Maris Salekešin Sigrid Vorobjov Methods:

More information

Guidelines For Services Providing Injecting Equipment

Guidelines For Services Providing Injecting Equipment Guidelines For Services Providing Injecting Equipment Best Practice Recommendations For Commissioners and Injecting Equipment Provision (IEP) Services in Scotland (Scottish Government 2010) January 2014

More information

Overlapping Epidemics:HIV/TB/IDU. Time for action! Sergey Filippovych, Associate Director: Treatment Olga Denisiuk Programme Officer : HIV/TB

Overlapping Epidemics:HIV/TB/IDU. Time for action! Sergey Filippovych, Associate Director: Treatment Olga Denisiuk Programme Officer : HIV/TB Overlapping Epidemics:HIV/TB/IDU. Time for action! Sergey Filippovych, Associate Director: Treatment Olga Denisiuk Programme Officer : HIV/TB 1 www.aidsalliance.org.ua Ukraine Ukraine: key context information:

More information

Psychiatric Treatment in Estonia. Andres Lehtmets Psychiatric Center of East Tallinn Central Hospital

Psychiatric Treatment in Estonia. Andres Lehtmets Psychiatric Center of East Tallinn Central Hospital Psychiatric Treatment in Estonia Andres Lehtmets Psychiatric Center of East Tallinn Central Hospital 06.10.2011 Health Insurance Transition to a new system of health insurance was made in 1992. Since that

More information

SESSION VI: Forecasting, estimating requirements for Procurement of HIV related supplies

SESSION VI: Forecasting, estimating requirements for Procurement of HIV related supplies ENSURING SECURE and RELIABLE SUPPLY and DISTRIBUTION SYSTEMS in DEVELOPING COUNTRIES, in the CONTEXT OF HIV/AIDS and PMTCT SESSION VI: Forecasting, estimating requirements for Procurement of HIV related

More information

Integration of collaborative TB/HIV activities with harm reduction services

Integration of collaborative TB/HIV activities with harm reduction services Integration of collaborative TB/HIV activities with harm reduction services Maryna Zelenskaya Ph D State service on HIV/AIDS and other socially diseases control, Head of Department on HIV/AIDS combating

More information

Models of good practice in drug treatment in Europe. Project group

Models of good practice in drug treatment in Europe. Project group Models of good practice in drug treatment in Europe ( moretreat 2006329 ) Project group Hamburg, London, Rome, Stockholm, Vienna, Warsaw, Zurich Project duration: 17 months from April 2006 August 2008

More information

TB/HIV Collaborative activities in Rwanda: From Policy to implementation.

TB/HIV Collaborative activities in Rwanda: From Policy to implementation. TB/HIV Collaborative activities in Rwanda: From Policy to implementation. Michel GASANA MD,MPH Head of TB and Other Respiratory Diseases Division. Rwanda / Ministry of Health RWANDA Superficie: 26,338

More information

Overview of the Activities of Estonian Pharmacies

Overview of the Activities of Estonian Pharmacies No of inhabitants Overview of the Activities of Estonian Pharmacies Number of Pharmacies There are three types of pharmacies in Estonia: general pharmacies, veterinary pharmacies and hospital pharmacies.

More information

TB Infection Control Policy. Scaling-up the implementation of collaborative TB/HIV activities in the Region of the

TB Infection Control Policy. Scaling-up the implementation of collaborative TB/HIV activities in the Region of the TB Infection Control Policy Scaling-up the implementation of collaborative TB/HIV activities in the Region of the Infection Control is aimed at minimizing the risk of TB transmission within populations

More information

Scaling Up Treatment in Zimbabwe: The path to high coverage

Scaling Up Treatment in Zimbabwe: The path to high coverage Scaling Up Treatment in Zimbabwe: The path to high coverage IAS Conference Dr. Tsitsi Mutasa-Apollo ART Programme Coordinator, Zimbabwe 30 th June, 2013 Kuala Lumpur, Malaysia Outline Introduction Background

More information

Scaling up collaborative TB/HIV activities: achievements, challenges, and opportunities in Viet Nam

Scaling up collaborative TB/HIV activities: achievements, challenges, and opportunities in Viet Nam Scaling up collaborative TB/HIV activities: achievements, challenges, and opportunities in Viet Nam 20 th International AIDS Conference, 20 July 2014, Melbourne, Australia Nguyen Hoang Long, MD, Ph.D.

More information

ASF epidemiological situation in Estonia update. PAFF meeting Brussels Estonian Veterinary and Food Board 1

ASF epidemiological situation in Estonia update. PAFF meeting Brussels Estonian Veterinary and Food Board 1 ASF epidemiological situation in Estonia update PAFF meeting Brussels 09.09.2015 Estonian Veterinary and Food Board 1 ASF in wild boars (1) Wild boar population Hunters estimation for the number of wild

More information

Opioid Substitution Treatment in Christchurch

Opioid Substitution Treatment in Christchurch Opioid Substitution Treatment in Christchurch Of CORS you can do it Leadership Day 20 November 2014 Dr Carmen Lowe, Clinical Head, Consultant Psychiatrist and Addiction Specialist Kaye Johnston Service

More information

TB: INTEGRATION IN HARM REDUCTION PACKAGES. ICF "AIDS Foundation East-West (AFEW Ukraine) Tbilisi, 2015

TB: INTEGRATION IN HARM REDUCTION PACKAGES. ICF AIDS Foundation East-West (AFEW Ukraine) Tbilisi, 2015 TB: INTEGRATION IN HARM REDUCTION PACKAGES ICF "AIDS Foundation East-West (AFEW Ukraine) Tbilisi, 2015 Ʃ = 185 760 «D» 45 083 / 38 126 TB Epidemiology in Ukraine Active TB prevalence in Ukraine (per 100,

More information

GLOBAL AIDS MONITORING REPORT

GLOBAL AIDS MONITORING REPORT KINGDOM OF SAUDI ARABIA MINISTRY OF HEALTH GLOBAL AIDS MONITORING REPORT COUNTRY PROGRESS REPORT 2017 KINGDOM OF SAUDI ARABIA Submission date: March 29, 2018 1 Overview The Global AIDS Monitoring 2017

More information

World Health Organization HIV/TB Facts 2011

World Health Organization HIV/TB Facts 2011 World Health Organization HIV/TB Facts 20 Note: The facts and figures of the HIV/TB Facts 20 are drawn from WHO HIV and TB surveillance data from 200 and 2009, as referenced below. Why is tuberculosis

More information

Dr James Peters was a drug addicted anaesthetist who infected 55 women with Hepatitis C between June 2008 and November 2009.

Dr James Peters was a drug addicted anaesthetist who infected 55 women with Hepatitis C between June 2008 and November 2009. R v James [Insert Latham Title] Peters Presented by by [Insert Brit Mainhoff Speaker] [Insert date as: Day, 12 September # Month Year] 2013 Background drug use Dr James Peters was a drug addicted anaesthetist

More information

Catalyst for Change. Viral Hepatitis Control Program Country Model Ukraine. Zahedul Islam

Catalyst for Change. Viral Hepatitis Control Program Country Model Ukraine. Zahedul Islam Catalyst for Change Viral Hepatitis Control Program Country Model Ukraine Zahedul Islam Director: Treatment, Procurement & Supply Alliance for Public Health Ukraine Alliance for Public Health Alliance

More information

Strengthening integration of TB and tobacco control in primary care through ICT tools

Strengthening integration of TB and tobacco control in primary care through ICT tools Strengthening integration of TB and tobacco control in primary care through ICT tools Dongbo Fu WHO/PND/TFI 1 Outline Background Scientific foundations Potential impact PND-GTP earlier collaboration and

More information

Christian Gunneberg MO WHO The 14th Core Group Meeting of the TB/HIV Working Group November 11-12, 2008, Addis Ababa, Ethiopia

Christian Gunneberg MO WHO The 14th Core Group Meeting of the TB/HIV Working Group November 11-12, 2008, Addis Ababa, Ethiopia The revised TB/HIV indicators and update on the process of harmonization Christian Gunneberg MO WHO The 14th Core Group Meeting of the TB/HIV Working Group November 11-12, 2008, Addis Ababa, Ethiopia Monitoring

More information

COUNTRY REPORT: EPIDEMIOLOGICAL SITUATIONS AND PROJECT ACTIVITIES

COUNTRY REPORT: EPIDEMIOLOGICAL SITUATIONS AND PROJECT ACTIVITIES COUNTRY REPORT: EPIDEMIOLOGICAL SITUATIONS AND PROJECT ACTIVITIES BIRUTE SEMENAITE, MEDICAL DIVISION OF PRISON DEPARTMENT AT THE MINISTRY OF JUSTICE OF THE REPUBLIC OF LITHUANIA LITHUANIAN PRISONS. BACKGROUND:

More information

The Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific

The Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific Health System Strengthening and Sustaining the Response The Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific Jintana Ngamvithayapong-Yanai, Ph.D. On behalf of TB/HIV Working Group, the

More information

Mid study Advisory Group Meeting, 14 th February 2011

Mid study Advisory Group Meeting, 14 th February 2011 Work Package 3 ( WP3 ): Tuberculosis related service needs, and accessibility and quality of HIV/TB integrated service provision, among injecting drug users Mid study Advisory Group Meeting, 14 th February

More information

Lewisham Pharmaceutical Needs Assessment Appendix E - Providers Consultation

Lewisham Pharmaceutical Needs Assessment Appendix E - Providers Consultation Lewisham Pharmaceutical Needs Assessment - 2018 Appendix E - Providers Consultation Lewisham Pharmacy contractors were invited to complete a questionnaire as part of the PNA consultation. The survey was

More information

Kingdom of Cambodia Nation Religion King. Ministry of Health. Annual Report National Center for HIV/AIDS, Dermatology and STD

Kingdom of Cambodia Nation Religion King. Ministry of Health. Annual Report National Center for HIV/AIDS, Dermatology and STD Kingdom of Cambodia Nation Religion King Ministry of Health Annual Report 2016 National Center for HIV/AIDS, Dermatology and STD May 2017 Contents A. GENERAL REPORT 1. BACKGROUND 1.1 Introduction 1.2

More information

Protecting and Promoting Health and Equity

Protecting and Promoting Health and Equity Meeting People Where They re at: Locating SFDPH s Hepatitis C Initiative in a Legacy of Drug User Health Services Protecting and Promoting Health and Equity Presented by: Katie Burk, MPH 1 San Francisco

More information

Integrating hepatitis C treatment in a regional setting The Cairns Experience. DANA 2018 Morag Goodinson

Integrating hepatitis C treatment in a regional setting The Cairns Experience. DANA 2018 Morag Goodinson Integrating hepatitis C treatment in a regional setting The Cairns Experience DANA 2018 Morag Goodinson I would like to acknowledge the Traditional Owners of the land, and pay respect to Elders past, present

More information

TB/HIV Project in the Philippines. Yumiko Yanase

TB/HIV Project in the Philippines. Yumiko Yanase TB/HIV Project in the Philippines Yumiko Yanase 1 TB situation in the Philippines Global rank: 9th Incidence (all): 296 Prevalence (all): 458 TB mortality (all): 49 New MDR-TB: 3.2% Case types notified

More information

The impact of economic recession on drug users and drug treatment

The impact of economic recession on drug users and drug treatment The impact of economic recession on drug users and drug treatment Designing and implementing responsive drug policies under fiscal constraints: the case of Greece Meni Malliori Assoc. Prof. of Psychiatry

More information

Toronto Declaration: Strategies to control and eliminate viral hepatitis globally. A call for coordinated action

Toronto Declaration: Strategies to control and eliminate viral hepatitis globally. A call for coordinated action Toronto Declaration: Strategies to control and eliminate viral hepatitis globally A call for coordinated action Hepatitis B National Action Plan All countries should develop a national and/or regional

More information

Implementing HIV Screening at Hub and Spoke Sites and Other Drug Treatment Settings

Implementing HIV Screening at Hub and Spoke Sites and Other Drug Treatment Settings Implementing HIV Screening at Hub and Spoke Sites and Other Drug Treatment Settings Dennis Fleming, MA CDPH/Office of AIDS DHCS Statewide SUD Conference August 23, 2018 Anaheim, CA Agenda What s New in

More information

Estimating resource needs and gaps for harm reduction in Asia

Estimating resource needs and gaps for harm reduction in Asia Estimating resource needs and gaps for harm reduction in Asia Anne Bergenstrom IHRA s 20 th International Conference 20-23 April 2009 Bangkok, Thailand 1 Context Crucial role of injecting drug use in kick

More information

Poland nationalupdate

Poland nationalupdate Poland nationalupdate 16th October 2014 Annual expert meeting on Drug-related deaths (DRD) and Drug-related infectious diseases (DRID) Estimation of HIV and HCV prevalence among injecting drug users in

More information

ADVOCACY AND COLLABORATION FOR TB CONTROL

ADVOCACY AND COLLABORATION FOR TB CONTROL WHO/HTM/TB/2005.347h Management of Tuberculosis Training for District TB Coordinators H ADVOCACY AND COLLABORATION FOR TB CONTROL World Health Organization Geneva 2005 Acknowledgements Management of Tuberculosis

More information

Integrated Safeguards Data Sheet (Initial)

Integrated Safeguards Data Sheet (Initial) THE WORLD BANK GROUP InfoShop Date Prepared/Updated: 10/25/2002 Section I - Basic Information Integrated Safeguards Data Sheet (Initial) 25025 A. Basic Project Data Country: MOLDOVA Project ID: P074122

More information

The next steps

The next steps Greater Manchester Hepatitis C Strategy The next steps 2010-2013 Endorsed by GM Director of Public Health group January 2011 Hepatitis Greater Manchester Hepatitis C Strategy 1. Introduction The Greater

More information

AIDS Prevention and Control Act

AIDS Prevention and Control Act AIDS Prevention and Control Act The Regulations became legally effective after public notification was made by the President on Dec. 17, 1990 An amendment of the Regulations comprising the addition of

More information

Uganda. HIV Country Pro le: Maternal mortality per live births (2015) Health expenditure, total (% of GDP) (2015)

Uganda. HIV Country Pro le: Maternal mortality per live births (2015) Health expenditure, total (% of GDP) (2015) WHO/CDS/HIV/18.50 Demographic and socioeconomic data Uganda HIV Country Pro le: 2017 42.9 million Total population (2017) 1 820 US$ GNI per capita, PPP (2017) 343 Maternal mortality per 100 000 live births

More information